Stabilized plasmid-lipid particles: construction and characterization.
about
Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeuticsUltrasound-enhanced microfluidic synthesis of liposomes.Cationic lipid nanodisks as an siRNA delivery vehicleSurface functionalized cationic lipid-DNA complexes for gene delivery: PEGylated lamellar complexes exhibit distinct DNA-DNA interaction regimesCationic lipid-mediated transfection in vitro and in vivo (review).Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs.Combinatorial library strategies for synthesis of cationic lipid-like nanoparticles and their potential medical applications.Nanolipoparticles-mediated MDR1 siRNA delivery reduces doxorubicin resistance in breast cancer cells and silences MDR1 expression in xenograft model of human breast cancer.Addition of ascorbic acid to the extracellular environment activates lipoplexes of a ferrocenyl lipid and promotes cell transfectionLiposome-encapsulated polyethylenimine/oligonucleotide polyplexes prepared by reverse-phase evaporation technique.Cationic lipid-DNA complexes for non-viral gene therapy: relating supramolecular structures to cellular pathways.Cell-specific targeting of lipid-based carriers for ODN and DNA.Parallel lipoplex folding pathways revealed using magnetic tweezersA covalently stabilized lipid-polycation-DNA (sLPD) vector for antisense oligonucleotide deliverySheddable coatings for long-circulating nanoparticles.Liposomal nanomedicines.Chemical activation of lipoplexes formed from DNA and a redox-active, ferrocene-containing cationic lipid.Electron spin resonance spectroscopy in drug delivery.Cationic liposome-nucleic acid complexes for gene delivery and silencing: pathways and mechanisms for plasmid DNA and siRNA.Influence of polyethylene glycol density and surface lipid on pharmacokinetics and biodistribution of lipid-calcium-phosphate nanoparticles.Challenges in the pharmaceutical development of lipid-based short interfering ribonucleic acid therapeutics.Nucleic-acid based gene therapeutics: delivery challenges and modular design of nonviral gene carriers and expression cassettes to overcome intracellular barriers for sustained targeted expression.Delivery of RNAi therapeutics: work in progress.Challenging the future of siRNA therapeutics against cancer: the crucial role of nanotechnology.Delivering the promise of small ncRNA therapeutics.Interference of poly(ethylene glycol)-lipid analogues with cationic-lipid-mediated delivery of oligonucleotides; role of lipid exchangeability and non-lamellar transitions.Self-assembling micelle-like nanoparticles based on phospholipid-polyethyleneimine conjugates for systemic gene delivery.Mastering Dendrimer Self-Assembly for Efficient siRNA Delivery: From Conceptual Design to In Vivo Efficient Gene Silencing.Co-delivery of doxorubicin and PEGylated C16-ceramide by nanoliposomes for enhanced therapy against multidrug resistance.Preparation, characterization, and efficient transfection of cationic liposomes and nanomagnetic cationic liposomesFolate-targeted liposome encapsulating chitosan/oligonucleotide polyplexes for tumor targeting.Lipid nanoparticle delivery systems for siRNA-based therapeutics.Transferrin receptor-targeted lipid nanoparticles for delivery of an antisense oligodeoxyribonucleotide against Bcl-2.The effect of cholesterol domains on PEGylated liposomal gene delivery in vitroDevelopment of lipidoid-siRNA formulations for systemic delivery to the liver.Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells.Targeting of stabilized plasmid lipid particles to hepatocytes in vivo by means of coupled lactoferrin.Cellular gene transfer mediated by influenza virosomes with encapsulated plasmid DNA.Relationship between the physical shape and the efficiency of oligomeric chitosan as a gene delivery system in vitro and in vivo.Stabilized plasmid-lipid particles for systemic gene therapy.
P2860
Q24616751-6CF694AB-85B0-48C5-9A67-F778414D7D82Q30448520-60074FD2-903B-4D38-AA11-C1F248AC6895Q33745473-4B4EAD25-828F-46C7-87F6-83BEA6F14DCCQ34184671-A1EB4EFF-4050-4160-BF8A-4882400F6591Q34313548-577C463B-2D18-43D7-BC55-3BD5991E9D5EQ34436572-F046AF24-F861-4E3C-BF90-4547F11AC25DQ35568750-40857B88-097A-4D8D-AA9A-1EA76D14B6EBQ35630481-AC0D22BF-FB47-4A77-A1BD-DCC9C00F0A7BQ35675391-C37A9630-973F-48D5-906C-E1A75736BFA0Q35999058-DC0DF1F3-8D95-42BB-BAA9-01A746DE189AQ36040801-64BDF414-24BF-4E76-8C01-C716BC0E2779Q36272601-E83706F5-34BA-4E79-8CA9-B4B7C229ABD2Q36334727-98488612-6D67-4C24-866C-4035C8AAFCEFQ36691274-2D7E5246-3CFA-4C5D-96C5-8A9B9603DDA1Q36841604-F4D882F8-3B2A-4C2F-875C-919718E99738Q37039021-5C2F86DA-EEC1-46CF-BAF7-8587342BDB18Q37105021-5BE78FFA-63AF-40F3-B974-06EDCBEA4563Q37352715-88086860-80A0-4B6C-BD66-61E562A83C20Q37403081-0FEA523F-F656-4599-8942-A5A111B66A06Q37588032-7B135522-F656-409D-8F10-9EC2D18B94B2Q37976494-C111EC2D-0AE2-4C0B-8176-54ECE880C473Q37981217-2733005A-3681-4E5D-89E0-004857162328Q38160246-29A8F795-30F8-47CB-B427-4205265F42E8Q38162098-99664908-875B-49D6-89BE-5D6426034017Q38226666-FB475AE6-E05F-4134-9EC0-6140BC211879Q38288939-D2B9A087-1C45-47DC-83F0-BCF3E4976E62Q38598120-437AC581-1DDC-464A-90B0-74F5639E4E8BQ38860419-B0343607-9915-499A-AE72-03B7C3CB742AQ38862896-74455914-E113-477B-A1A8-C27D1B2EC5C4Q38885218-B75768AF-1808-45A0-B670-32EABF6D7969Q38993006-B3B6B4C8-E464-4EDA-B296-5F338D906828Q39027758-A3580749-3E56-499F-9649-0F2564573146Q39323667-D2D94A18-CAEA-491C-8DDB-336883D70748Q39377390-8CB6D648-EE78-418D-BE27-B6FCDBFB28AEQ39506235-CAB88F69-F72A-485F-BE7F-7E33888B384FQ39913293-0D419C79-2572-47F8-A871-4008F996155CQ40060375-982D38A8-8490-4EB4-98C9-810BE41F61A9Q40159983-43B3FA8F-2454-4D2C-AD15-C494EA061EEAQ40675811-D86DD140-9F9A-412F-96C8-B26ECC81BE2EQ41631274-8291C3B7-9348-4371-99A2-BE7D5C1EBA7E
P2860
Stabilized plasmid-lipid particles: construction and characterization.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Stabilized plasmid-lipid particles: construction and characterization.
@en
type
label
Stabilized plasmid-lipid particles: construction and characterization.
@en
prefLabel
Stabilized plasmid-lipid particles: construction and characterization.
@en
P2093
P2860
P356
P1433
P1476
Stabilized plasmid-lipid particles: construction and characterization.
@en
P2093
MacLachlan I
Ossanlou M
Scherrer P
Wheeler JJ
P2860
P2888
P304
P356
10.1038/SJ.GT.3300821
P577
1999-02-01T00:00:00Z
P5875
P6179
1041443639